Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Different Susceptibility To Smoking-induced DNA Damage Among Male And Female Lung Cancer Patients.

D. Ryberg, A. Hewer, D. Phillips, A. Haugen
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The levels of aromatic/hydrophobic DNA adducts were analyzed in normal lung tissue from 63 lung cancer patients and examined in relation to exposure and genetic factors. Adduct levels were significantly higher in smokers than in nonsmokers, but among smokers the number of cigarettes smoked per day had only low significance for the variation in adduct levels. An inverse correlation was found between years of smoking and DNA adduct levels (r = 0.52, P = 0.001). Thus, patients with high adduct levels generally had shorter duration of smoking and/or lower smoking dose before the clinical onset of the disease, which fits expected behavior of cancer susceptible individuals. The data indicated an excess of individuals with glutathione S-transferase M1 deficiency among male patients with high adduct levels. Among females the DNA adduct levels were higher than in males when adjusted for smoking dose. There was a highly significant difference in the distribution of males and females when smokers were divided into quartile groups according to adducts per pack year (trend test: 2-sided P = 0.005). This may indicate that women are at greater risk of tobacco-induced lung cancer.
This paper references
Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.
J. Seidegård (1988)
Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers
E. Zang (1992)
Increasedcytogenetic damage in smokers deficient in glutathione S-transferase isozyme @s
vanPoppel (1992)
Influence of cigarettesmokingon thelevels of DNA adductsin humanbronchialepitheium and white blood cells . hit
D. H. Phillips (1990)
Formation of DNA adductsandwater-solublemetabolitesof benzo(a)pyrenein humanmono cytes is genetically controlled
D. Nowak (1988)
p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.
D. Ryberg (1994)
Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type.
H. Risch (1993)
DNA adducts, mutations and cancer.
K. Hemminki (1993)
Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.
H. Bartsch (1992)
Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
S. Petruzzelli (1988)
DNA adductsin bronchialbiopsies. Int. J. Cancer
B P Dunn (1991)
Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
P. Shields (1993)
Roleof geneticsanddrugmetabolismin humancancerrisk.Mutat
D. W. Nebert (1991)
The human glutathione S-transferase supergene family,its polymorphism, and its effectson susceptibilityto lungcancer.Environ
B. Kettcrcr (1992)
Smokingandperipheraltypeof cancer are related to high levels of pulmonary cytochrome P 4501 A in lung cancer patients
S. Anttila (1991)
Cumulative tar exposure. A new index for estimating lung cancerrisk amongcigarettesmokers.Cancer(Phila.)
E. A. Zang (1992)
Hereditarydiffer ences in the expression of the human glutathione transferase active in trans - stilbene oxide aredue to a gene deletion
J. SeidegArd (1988)
Is environmental carcinogenesis modulated by host polymorphism?
J. Idle (1991)
Roleof geneticsanddrugmetabolismin humancancerrisk
D. W. Nebert (1991)
Increasedcytogenetic damage in smokers deficient in glutathione S-transferase isozyme @s
Van Poppel (1992)
Doezjer, 0., and Lehnert, G. Reduced O@-methylguaninerepair in fibroblast cultures from patients withlungcancer
H W Rudiger (1989)
Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage.
J. Wiencke (1990)
Formation of DNA adductsand water-solublemetabolitesof benzo(a)pyrenein humanmono cytes is genetically controlled. tot
D Nowak (1988)
Relationships between DNA adduct formation and carcinogenesis.
J. Swenberg (1985)
Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers.
O. Geneste (1991)
The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.
B. Ketterer (1992)
Influence of cigarettesmokingon the levels of DNA adductsin humanbronchialepitheium and white blood cells. hit
D H Phillips (1990)
DNA adductsin bronchialbiopsies
B. P. Dunn (1991)
Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
K. Nakachi (1993)
Smokingandperipheral typeof cancer are related to high levels of pulmonary cytochrome P4501A in lung cancer patients
S Anttila (1991)
Influence of cigarettesmokingon thelevels of DNA adductsin humanbronchialepitheium and white blood cells
D. H. Phillips (1990)
Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct forma tionin highrisksubjectsfor tobacco-related lungcancer.Toxicol.LctL,64/65: 477—483
H. Bartsch (1992)
Carcinogen metabolism in human luiig tissues and the effect of tobacco smoking : results from a case . control multicenter study an lung cancer pelients Environ
H. Bartsch
Correlation of DNA adduct levels in human lung with cigarette smoking
D. Phillips (1988)
Reduced O@-methylguaninerepair in fibroblast cultures from patients withlungcancer
H. W. Rudiger (1989)
Roleof geneticsanddrugmetabolism in human cancerrisk
D W Nebert (1991)

This paper is referenced by
The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women
A. Engeland (2004)
Gender- specificaspectsof epidemiology,moleculargeneticsand outcome:lungcancer
N. Mederos (2020)
Molecular epidemiology of lung cancer 91
P. Shields (1999)
The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer
C. Gallagher (2007)
75 – Epidemiology of Lung Cancer in Women
A. Wu (2000)
Epidemiology of Lung Cancer in Women
A. Wu (2013)
A mulher e o cancro do pulmão
E. Teixeira (2003)
The role of individual susceptibility in cancer burden related to environmental exposure.
H. Bartsch (1996)
Gender Difference in Systemic Oxidative Stress and Antioxidant Capacity in Current and Former Heavy Smokers
I. A. Hakim (2012)
The Gender-Specific Aspects of Lung Cancer
R. Toonkel (2010)
Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts
S. Mollerup (2006)
Cancer: Clinical Challenges and Opportunities
D. Beer (2005)
Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer
W. P. Bennett (1999)
Characteristics of patients with lung cancer under the age of 45 years: A case control study
M. Cornere (2001)
A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds.
R. Godschalk (2003)
Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study
M. Imboden (2007)
Differential Effect of Active Smoking on Gene Expression in Male and Female Smokers
Sunirmal Paul (2014)
Lung Cancer in Women: A Modern Epidemic.
Christina R MacRosty (2020)
TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men
A. Marrogi (2005)
Lung cancer: epidemiology, etiology, and prevention.
C. D. Dela Cruz (2011)
Promoter Hypermethylation Is the Predominant Mechanism in hMLH1 and hMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer
Han-Shui Hsu (2005)
[Occupational factors influencing lung cancer in women in epidemiological studies].
B. Świątkowska (2011)
Point mutations in normal lungs of smokers and non-smokers
Hiroko Sudo (2004)
Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis.
Y. Wang (2002)
Bulky DNA Adducts, Tobacco Smoking, Genetic Susceptibility, and Lung Cancer Risk.
A. Munnia (2017)
The molecular epidemiology of lung cancer.
S. Spivack (1997)
S. Spivack (2001)
Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk
M. Schabath (2005)
Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract.
K. Szyfter (1999)
Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
E. Chan (2005)
Sex differences in lung cancer survival: do tumors behave differently in elderly women?
J. Wisnivesky (2007)
Gene-Environment Interaction for the ERCC 2 Polymorphisms and Cumulative Cigarette Smoking Exposure in Lung Cancer 1
W. Zhou (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar